Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Clinical trial NCT02884037 · COMPLETED

Trial details

NCT number: NCT02884037
Sponsor: Mansoura University
Status: COMPLETED
Study type: OBSERVATIONAL

Non-alcoholic Fatty Liver Disease

Start date: 2012-05-01
Primary completion: 2015-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.